Samsung Bioepis

Pharma

Pfizer, Alzheimer's blood test, Samsung—Fierce Pharma Asia

Pfizer joined the PD-1xVEGF bispecific race. The FDA approved its first Alzheimer's blood test. Samsung Biologics plans a biosimilar spinoff. And more.

Angus Liu May 23, 2025 9:00am

CDMO Samsung Biologics telegraphs spinoff of biosim unit

May 22, 2025 11:41am

Eisai, ex-NMPA official, Pfizer-Summit—Fierce Pharma Asia

Feb 28, 2025 8:45am

Justice court courtroom legal lawsuit sue litigation

J&J sues Samsung Bioepis over Stelara biosimilar agreement

Feb 25, 2025 10:21am

Regeneron loses bid to block Amgen's Eylea biosim, sinking shares

Sep 24, 2024 10:32am

Samsung Biologics' 37% sales surge propelled by biosimilars

Jul 24, 2024 10:56am